<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Dyphylline</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00651</strong>&#160; (APRD00769)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>A theophylline derivative with broncho- and vasodilator properties. It is used in the treatment of asthma, cardiac dyspnea, and bronchitis. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00651/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00651/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00651.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00651.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00651.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00651.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00651.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00651">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>(&#177;)-diprophylline</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>(&#177;)-dyphylline</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>7-(&#946;,&#947;-dihydroxypropyl)theophylline</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Dihydroxypropyl theopylin</td><td>German</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Diprophylline</td><td><span class="wishart wishart-not-available">Not Available</span></td><td>INN</td></tr></tbody></table></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Corphyllin</td><td>Nippon Shinyaku</td></tr><tr><td>Dilor</td><td>Savage</td></tr><tr><td>Lufyllin</td><td>Mallinckrodt</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/phosphodiesterase-inhibitors">Phosphodiesterase Inhibitors</a></li>
<li><a href="/mesh/bronchodilator-agents">Bronchodilator Agents</a></li>
<li><a href="/mesh/vasodilator-agents">Vasodilator Agents</a></li>
<li><a href="/mesh/muscle-relaxants-respiratory">Muscle Relaxants, Respiratory</a></li></ul></td></tr><tr><th>CAS number</th><td>479-18-5</td></tr><tr><th>Weight</th><td>Average: 254.2426<br>Monoisotopic: 254.101504956</td></tr><tr><th>Chemical Formula</th><td>C<sub>10</sub>H<sub>14</sub>N<sub>4</sub>O<sub>4</sub></td></tr><tr><th>InChI Key</th><td>KSCFJBIXMNOVSH-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C10H14N4O4/c1-12-8-7(9(17)13(2)10(12)18)14(5-11-8)3-6(16)4-15/h5-6,15-16H,3-4H2,1-2H3</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">7-(2,3-dihydroxypropyl)-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione</div></td></tr><tr><th>SMILES</th><td><div class="wrap">CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Heterocyclic Compounds</td></tr><tr><th>Class</th><td>Imidazopyrimidines</td></tr><tr><th>Subclass</th><td>Purines and Purine Derivatives</td></tr><tr><th>Direct parent</th><td>Xanthines</td></tr><tr><th>Alternative parents</th><td>Purinones; Pyrimidones; N-substituted Imidazoles; Secondary Alcohols; 1,2-Diols; Polyamines; Primary Alcohols</td></tr><tr><th>Substituents</th><td>pyrimidone; pyrimidine; n-substituted imidazole; imidazole; azole; polyol; 1,2-diol; secondary alcohol; polyamine; primary alcohol; amine; alcohol; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For relief of acute bronchial asthma and for reversible bronchospasm associated with chronic bronchitis and emphysema.</td></tr><tr><th>Pharmacodynamics</th><td>Dyphylline, a xanthine derivative, is a bronchodilator used for relief of acute bronchial asthma and for reversible bronchospasm associated with chronic bronchitis and emphysema. Dyphylline is a xanthine derivative with pharmacologic actions similar to theophylline and other members of this class of drugs. Its primary action is that of bronchodilation, but it also exhibits peripheral vasodilatory and other smooth muscle relaxant activity to a lesser degree.</td></tr><tr><th>Mechanism of action</th><td>The bronchodilatory action of dyphylline, as with other xanthines, is thought to be mediated through competitive inhibition of phosphodiesterase with a resulting increase in cyclic AMP producing relaxation of bronchial smooth muscle as well as antagonism of adenosine receptors.</td></tr><tr><th>Absorption</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td>84%</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Hepatic</p></td></tr><tr><th>Route of elimination</th><td>Dyphylline exerts its bronchodilatory effects directly and, unlike the&#173;ophylline, is excreted unchanged by the kidneys without being metabolized by the liver. Approximately 88% of a single oral dose can be recovered from the urine unchanged.</td></tr><tr><th>Half life</th><td>2 hours (range 1.8 - 2.1 hours)</td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>LD<sub>50</sub>=1954 mg/kg (orally in mice)</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.964</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              -
        </td>
        <td>0.6357</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.7332</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.5999</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9775</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9792</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9289</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.8343</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.8429</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.5446</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9046</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.907</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.946</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9025</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.978</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.9758</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.799
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.8576
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.6129
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          1.8401 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9489
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.8734
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Teva pharmaceuticals usa inc</li>
<li>Savage laboratories inc div altana inc</li>
<li>Meda pharmaceuticals inc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.bpirx.com">Breckenridge Pharmaceuticals</a></li>
<li><a href="http://greatsouthernlabs.com">Great Southern Laboratories</a></li>
<li>Lunsco Inc.</li>
<li><a href="http://www.meda.se">Meda AB</a></li>
<li><a href="http://www.novartis.com">Novartis AG</a></li>
<li><a href="http://www.savagelabs.com">Savage Labs</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Tablet</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr><th>Prices</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="prices"><thead><tr><th>Unit description</th><th>Cost</th><th>Unit</th></tr></thead><tbody><tr><td>Afinitor 10 mg tablet</td><td>247.58USD</td><td>tablet</td></tr><tr><td>Afinitor 5 mg tablet</td><td>234.75USD</td><td>tablet</td></tr><tr><td>Lufyllin-400 tablet</td><td>4.62USD</td><td>tablet</td></tr><tr><td>Lufyllin 200 mg tablet</td><td>3.15USD</td><td>tablet</td></tr><tr><td>Dyphylline gg es tablet</td><td>0.78USD</td><td>tablet</td></tr><tr><td>Dyphylline gg tablet</td><td>0.69USD</td><td>tablet</td></tr></tbody></table><div class="alert alert-warning clearfix">DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.</div></td></tr><tr><th>Patents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="properties"><th class="divider" colspan="2">Properties</th></tr><tr><th>State</th><td>solid</td></tr><tr><th>Experimental Properties</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr><tr><td>melting point</td><td>155-157</td><td>Jones, J.W. and Maney, P.V.; U.S. Patent 2,575,344; November 20,1951; assigned to the
State of Iowa.</td></tr><tr><td>water solubility</td><td>3.33E+005 mg/L (at 25 &#176;C)</td><td>MERCK INDEX (1996)</td></tr><tr><td>logP</td><td>-1.9</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>logS</td><td>-0.17</td><td>ADME Research, USCD</td></tr></table></td></tr><tr><th>Predicted Properties</th><td class="data-table-container"><table class="table table-condensed table-striped"><thead><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr></thead><tbody><tr><td>water solubility</td><td>1.43e+01 g/l</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>-0.98</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>-1.9</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#logp_logd">ChemAxon</a></td></tr><tr><td>logS</td><td>-1.2</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>pKa (strongest acidic)</td><td>13.91</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>pKa (strongest basic)</td><td>-0.97</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>physiological charge</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>hydrogen acceptor count</td><td>5</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>hydrogen donor count</td><td>2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>polar surface area</td><td>98.9</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topolgical_surface">ChemAxon</a></td></tr><tr><td>rotatable bond count</td><td>3</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>refractivity</td><td>62.09</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#refractivity">ChemAxon</a></td></tr><tr><td>polarizability</td><td>24.65</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>number of rings</td><td>2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>bioavailability</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>rule of five</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Ghose filter</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Veber's rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>MDDR-like rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="references"><th class="divider" colspan="2">References</th></tr><tr><th>Synthesis Reference</th><td><span class="citations"><p>Jones, J.W. and Maney, P.V.; U.S. Patent 2,575,344; November 20,1951; assigned to the<br>
State of Iowa.</p></span></td></tr><tr><th>General Reference</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>External Links</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Resource</th><th>Link</th></tr></thead><tbody><tr><td>KEGG Drug</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?drug:D00691" target="_blank">D00691 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>KEGG Compound</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?cpd:C07819" target="_blank">C07819 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Compound</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=3182" target="_blank">3182 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Substance</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46504443" target="_blank">46504443 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChemSpider</td><td><a class="wishart-link-out" href="http://www.chemspider.com/Chemical-Structure.3070.html" target="_blank">3070 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEBI</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=4728" target="_blank">4728 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEMBL</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1752" target="_blank">CHEMBL1752 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Therapeutic Targets Database</td><td><a class="wishart-link-out" href="http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000596" target="_blank">DAP000596 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PharmGKB</td><td><a class="wishart-link-out" href="http://www.pharmgkb.org/drug/PA164748027" target="_blank">PA164748027 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drug Product Database</td><td><a class="wishart-link-out" href="http://205.193.93.51/dpdonline/searchRequest.do?din=26751" target="_blank">26751 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>RxList</td><td><a class="wishart-link-out" href="http://www.rxlist.com/cgi/generic2/dyphylline.htm" target="_blank">http://www.rxlist.com/cgi/generic2/dyphylline.htm <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drugs.com</td><td><a class="wishart-link-out" href="http://www.drugs.com/cdi/dyphylline.html" target="_blank">http://www.drugs.com/cdi/dyphylline.html <span class="glyphicon glyphicon-new-window"> </span></a></td></tr></tbody></table></td></tr><tr><th>ATC Codes</th><td>R03DA01<ul class="atc-drug-tree"><li><a href="/atc/R#R">R &#8212; RESPIRATORY SYSTEM</a></li><li><a href="/atc/R03#R03">R03 &#8212; DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES</a></li><li><a href="/atc/R03D#R03D">R03D &#8212; OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES</a></li><li><a href="/atc/R03DA#R03DA">R03DA &#8212; Xanthines</a></li></ul></td></tr><tr><th>AHFS Codes</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>PDB Entries</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>FDA label</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>MSDS</th><td><a href="/system/msds/DB00651.pdf?1265922736">show</a>(65.7 KB)</td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00787">Aciclovir</a></td><td>Acyclovir increases the effect and toxicity of dyphylline.</td></tr><tr><td><a href="/drugs/DB00640">Adenosine</a></td><td>This xanthine decreases the effect of adenosine</td></tr><tr><td><a href="/drugs/DB01558">Bromazepam</a></td><td>Dyphylline may decrease the therapeutic effect of bromazepam. Monitor for changes in the therapeutic effects of bromazepam if dyphylline is initiated, discontinued or dose changed. </td></tr><tr><td><a href="/drugs/DB00564">Carbamazepine</a></td><td>Carbamazepine may decrease the serum concentration of diphylline. Diphylline may decrease the serum concentration of carbamazepine. Monitor for changes in the therapeutic effect of both agents if concomitant therapy is initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB00501">Cimetidine</a></td><td>Increases the effect of theophylline</td></tr><tr><td><a href="/drugs/DB00537">Ciprofloxacin</a></td><td>Ciprofloxacin may increase the effect of dyphylline.</td></tr><tr><td><a href="/drugs/DB01211">Clarithromycin</a></td><td>Increases the effect and toxicity of theophylline </td></tr><tr><td><a href="/drugs/DB00822">Disulfiram</a></td><td>Increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00199">Erythromycin</a></td><td>The macrolide, erythromycin, may increase the effect and toxicity of the theophylline derivative, dyphylline.</td></tr><tr><td><a href="/drugs/DB00977">Ethinyl Estradiol</a></td><td>The contraceptive increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00176">Fluvoxamine</a></td><td>Increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB01320">Fosphenytoin</a></td><td>Decreased effect of both products</td></tr><tr><td><a href="/drugs/DB00365">Grepafloxacin</a></td><td>Grepafloxacin may increase the effect of dyphylline.</td></tr><tr><td><a href="/drugs/DB00034">Interferon Alfa-2a, Recombinant</a></td><td>Interferon increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00105">Interferon Alfa-2b, Recombinant</a></td><td>Interferon increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00011">Interferon alfa-n1</a></td><td>Interferon increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00951">Isoniazid</a></td><td>Increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB01356">Lithium</a></td><td>Theophylline decreases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00379">Mexiletine</a></td><td>Mexiletine increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB01203">Nadolol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB01059">Norfloxacin</a></td><td>Norfloxacin may increase the effect of dyphylline.</td></tr><tr><td><a href="/drugs/DB00008">Peginterferon alfa-2a</a></td><td>Interferon increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00022">Peginterferon alfa-2b</a></td><td>Interferon increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00806">Pentoxifylline</a></td><td>Pentoxifylline increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB01174">Phenobarbital</a></td><td>The barbiturate, phenobarbital, decreases the effect of dyphylline.</td></tr><tr><td><a href="/drugs/DB00252">Phenytoin</a></td><td>Decreased effect of both products</td></tr><tr><td><a href="/drugs/DB00960">Pindolol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB00794">Primidone</a></td><td>The barbiturate, primidone, decreases the effect of dyphylline.</td></tr><tr><td><a href="/drugs/DB01182">Propafenone</a></td><td>Propafenone increases the effect of theophylline</td></tr><tr><td><a href="/drugs/DB00571">Propranolol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB01045">Rifampicin</a></td><td>Rifampin decreases the effect of theophylline</td></tr><tr><td><a href="/drugs/DB00231">Temazepam</a></td><td>Dyphylline may decrease the efficacy of Temazepam. Monitor for changes in the therapeutic effect of Temazepam if Dyphylline is initiated, discontinued or dose changed. </td></tr><tr><td><a href="/drugs/DB00857">Terbinafine</a></td><td>Terbinafine increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00208">Ticlopidine</a></td><td>Ticlopidine increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00373">Timolol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>